We maintain strong working relationships with international agencies and overseas regulators to help protect public health in Australia. These partnerships support our post-market monitoring of therapeutic goods and ensure our regulatory framework reflects international best practices.
We collaborate with global counterparts on joint projects and shared initiatives and actively participate in international forums to address key regulatory issues and emerging challenges.
To learn more about our current international engagement approach and key global business priorities, read the TGA international engagement strategy 2021-2025.
International forums
-
PagePublication of the updated Access Consortium Strategic Plan 2025-2028.
-
Corporate reportsICMRA brings together the heads of over 40 medicines regulatory authorities, with the WHO as an observer.
-
PageThe IMDRF promotes an efficient and effective medical devices sector.
-
PageIPRP creates an environment for its regulatory members and observers to exchange information.
-
PageHow we work with other regulators and organisations.
-
PageProject Orbis provides a framework for the collaborative review of promising new cancer treatments among international regulatory partners.
For more information about our work with overseas regulators and links to news coverage of events, see International collaboration highlights.
Past international engagement strategies
Our international engagement strategies provide the overarching direction for our international engagement and articulates our key international business priorities.
Use of international assessments
We often rely on assessments from comparable overseas regulators (CORs) and international assessment bodies to support our decision-making. This approach helps us reduce duplication and streamline our processes.
Depending on the type of therapeutic good, we apply specific criteria to determine which overseas regulators are considered comparable. To explore an example of this, view Use of market authorisation evidence from comparable overseas regulators and assessment bodies for medical devices (including IVDs).
Links to international agencies and organisations
Regulatory agencies
- Canada: Health Canada
- Europe: European Medicines Agency (EMEA)
- New Zealand: New Zealand Medicines and Medical Devices Safety Authority (Medsafe)
- Singapore: Health Sciences Authority (HSA)
- United Kingdom: Medicines and Healthcare Products Regulatory Agency (MHRA)
- United States of America: US Food & Drug Administration (US FDA)
Related forums, schemes and organisations
As of 1 January 2021, the UK is no longer in the European Union’s Single Market and Customs Union. See Brexit – Implications for therapeutic goods in Australia.
Page history
Moved page content from linked pages onto main page.
Moved page content from linked pages onto main page.